前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービス
文献複写のお申込み
JDreamⅢ複写サービスのご利用が初めての方
学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202251448435271   整理番号：22A0477011

低メチル化活性化癌精巣遺伝子LIN28Bは胃癌における細胞増殖と転移を促進する【JST・京大機械翻訳】

Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer
著者 (25件)：
Xu Jiani
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Xu Jiani
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Zhou Yan
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Zhou Yan
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Yang Jianshui
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Yang Jianshui
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Gu Yayun
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Gu Yayun
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Gu Yayun
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Zhang Erbao
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Zhang Erbao
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Yuan Wenwen
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Yuan Wenwen
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Wang Cheng
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Wang Cheng
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Wang Cheng
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Wang Cheng
(Department of Bioinformatics, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China)
, 
Jin Guangfu
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Jin Guangfu
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Ma Hongxia
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Ma Hongxia
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Ma Hongxia
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Hu Zhibin
(Department of Epidemiology and Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China)
, 
Hu Zhibin
(State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, China)
, 
Hu Zhibin
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China)

資料名：
Gene  (Gene)

巻： 813  ページ： Null  発行年： 2022年 
JST資料番号： E0701B  ISSN： 0378-1119  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

Copyright (c) 2009 Japan Science and Technology Agency. All Rights Reserved

TOP

BOTTOM